Popular artificial sweetener could lead to new treatments for aggressive cancers
Saccharin, the artificial sweetener that is the main ingredient in Sweet 'N Low, Sweet Twin and Necta, could do far more than just keep our waistlines trim. According to new research, this popular sugar substitute could potentially lead to the development of drugs capable of combating aggressive, difficult-to-treat cancers with fewer side effects.The last ten years of my life have been spent unlearning everything I was taught in the first forty.